LegoChem Biosciences Competitors and Similar CompaniesClear all

LegoChem Biosciences's competitors and similar companies include TRACON Pharmaceuticals, Nykode Therapeutics, Tvardi Therapeutics and Taiho Oncology.

	LegoChem Biosciences LegoChem Biosciences (레고켐바이오, LCB) is a research-based biotechnology company dedicated to the discovery, development, and commercialization of medicines.	TRACON Pharmaceuticals TRACON Pharmaceuticals is a biopharmaceutical company focused on developing targeted therapies for cancer and macular degeneration.	Nykode Therapeutics Nykode Therapeutics (formerly known as Vaccibody) is a biopharmaceutical company dedicated to the discovery and development of immunotherapies.	Tvardi Therapeutics Tvardi Therapeutics is a biotechnology company developing medicines for the treatment of cancer, chronic inflammation, and fibrosis.	Taiho Oncology Taiho Oncology is a pharmaceutical company engaged in the discovery and development of cancer treatments.
Founding Date	Founding Date 2006	Founding Date 2006	Founding Date 2007	Founding Date 2017	Founding Date 2002
Type	Type Public	Type Public	Type Public	Type Private	Type Subsidiary
Tags	Tags Healthcare biotech drug development oncology pharma	Tags Healthcare biotech drug development oncology pharma	Tags Healthcare biotech drug development oncology pharma	Tags Healthcare biotech drug development oncology pharma	Tags Healthcare biotech drug development oncology pharma
Locations	Locations HQ	Locations San Diego, US HQ	Locations Oslo, NO HQ	Locations Houston, US HQ Houston, US	Locations Singapore, SG HQ Oakville, CA Chiyoda City, JP Birmingham, GB Menlo Park, US Princeton, US
Employees	Employees 94	Employees 268% increase	Employees 135	Employees 19	Employees 4191% increase
Valuation ($)	Valuation ($) N/A	Valuation ($) 279.4 k	Valuation ($) 144.4 m	Valuation ($) N/A	Valuation ($) N/A
Financial
Revenue (est.)	Revenue (est.) ₩141.6b (FY, 2025)	Revenue (est.) $12m (FY, 2023)	Revenue (est.) N/A	Revenue (est.) N/A	Revenue (est.) N/A
Cost of goods	Cost of goods ₩11.4b (FY, 2025)	Cost of goods N/A	Cost of goods $1.3m (FY, 2025)	Cost of goods N/A	Cost of goods N/A
Gross profit	Gross profit ₩130.4b (FY, 2025)	Gross profit N/A	Gross profit ($801k) (FY, 2025)	Gross profit N/A	Gross profit N/A
Net income	Net income (₩91.5b) (FY, 2025)	Net income ($3.6m) (FY, 2023)	Net income ($12.2m) (FY, 2025)	Net income N/A	Net income N/A
Funding
Total funding raised	Total funding raised N/A	Total funding raised $ 41m	Total funding raised $ 31.5m	Total funding raised $ 88m	Total funding raised N/A